Printer Friendly

SUMMIT RECEIVES SECOND FDA 510(K) CLEARANCE FOR GLAUCOMA PRODUCT

 WALTHAM, Mass., Aug. 3 /PRNewswire/ -- Summit Technology, Inc. (NASDAQ: BEAM) today announced that the Food and Drug Administration has cleared, for commercial marketing and sale in the United States, a disposable handpiece for use in treating glaucoma with the company's OmniMed(TM) Holmium Laser System. This clearance is pursuant to Section 510(k) of the United States Food and Drug Law. In June, 1992, Summit received 510(k) clearance of the company's OmniMed Holmium Laser System for commercial marketing and sale in the United States for treatment of glaucoma.
 Summit Technology, Inc. is a worldwide leader in the development, manufacture and sale of ophthalmic laser systems designed to correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
 -0- 8/3/93
 /CONTACT: Paula Rainville, Summit Technology, 617-890-1234/
 (BEAM)


CO: Summit Technology, Inc. ST: Massachusetts IN: MTC SU: PDT

JL-CM -- NE004 -- 8727 08/03/93 08:43 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 3, 1993
Words:149
Previous Article:PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES THIRD QUARTER RESULTS
Next Article:SHARP DEBUTS ITS FIRST PERSONAL DIGITAL ASSISTANT WITH NEWTON INTELLIGENCE
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters